Angeline Ting Hui Goh

Suggest Changes
  • Citations Per Year
Learn More
e15538 Background: Sorafenib has been shown to significantly prolong survival in patients with nonresectable hepatocellular carcinoma (HCC) without however significant tumour regression. The addition(More)
  • 1